Novo Nordisk A/S (NVO)
37.31
-0.14
(-0.37%)
USD |
NYSE |
Mar 02, 11:50
Novo Nordisk Research and Development Expense (TTM) : 7.923B for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Ascendis Pharma A/S | 332.30M |
| Evaxion AS | 9.769M |
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| Viking Therapeutics, Inc. | 344.96M |
| DBV Technologies SA | 95.80M |